Oral Controlled Release Technology for Peptides: Status and Future Prospects
- 1 January 1996
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 13 (12), 1760-1764
- https://doi.org/10.1023/a:1016008419367
Abstract
In spite of significant efforts in academic and commercial laboratories, major breakthroughs in oral peptide and protein formulation have not been achieved. The major barriers to developing oral formulations for peptides and proteins include poor intrinsic permeability, lumenal and cellular enzymatic degradation, rapid clearance, and chemical and conformational stability. Pharmaceutical approaches to address these barriers, which have been successful with traditional, small, organic drug molecules, have not readily translated into effective peptide and protein formulations. The success achieved by Sandoz with cyclosporin formulations remains one clear example of what can be achieved, although it is likely that effective oral formulations for peptides and proteins will remain highly compound specific. Although the challenges are significant, the potential therapeutic benefit remains high, particularly with the increasing identification of potential peptide and protein drug candidates emerging from the biotechnology arena. Successful formulations will most likely require a systematic and careful merger of formulation and design delivery systems which maximize the potential for absorption across the epithelial cell layer.Keywords
This publication has 19 references indexed in Scilit:
- Enteral absorption of octreotide: modulation of intestinal permeability by distinct carbohydrates.1995
- Gastrointestinal absorption of peptide drug: quantitative evaluation of the degradation and the permeation of metkephamid in rat small intestine.1995
- Starch Microspheres Induce Pulsatile Delivery of Drugs and Peptides Across the Epithelial Barrier by Reversible Separation of the Tight JunctionsJournal of Drug Targeting, 1995
- Transepithelial Transport of Insulin: I. Insulin Degradation by Insulin-Degrading Enzyme in Small Intestinal EpitheliumPharmaceutical Research, 1995
- Enhancement of Intestinal Insulin Absorption by Bile Salt–Fatty Acid Mixed Micelles in DogsJournal of Pharmaceutical Sciences, 1994
- Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.1994
- Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in RatsPharmaceutical Research, 1994
- Hydrogels for Site-Specific Drug Delivery to the Colon: In Vitro and in Vivo DegradationPharmaceutical Research, 1992
- Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.1991
- Synthesis and biological activity of some transition-state inhibitors of human reninJournal of Medicinal Chemistry, 1988